Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk
Open Access
- 23 March 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (3) , e0117574
Abstract
Evidence on the association between vitamin D status and pancreatic cancer risk is inconsistent. This inconsistency may be partially attributable to variation in vitamin D regulating genes. We selected 11 vitamin D-related genes (GC, DHCR7, CYP2R1, VDR, CYP27B1, CYP24A1, CYP27A1, RXRA, CRP2, CASR and CUBN) totaling 213 single nucleotide polymorphisms (SNPs), and examined associations with pancreatic adenocarcinoma. Our study included 3,583 pancreatic cancer cases and 7,053 controls from the genome-wide association studies of pancreatic cancer PanScans-I-III. We used the Adaptive Joint Test and the Adaptive Rank Truncated Product statistic for pathway and gene analyses, and unconditional logistic regression for SNP analyses, adjusting for age, sex, study and population stratification. We examined effect modification by circulating vitamin D concentration (≤50, >50 nmol/L) for the most significant SNPs using a subset of cohort cases (n = 713) and controls (n = 878). The vitamin D metabolic pathway was not associated with pancreatic cancer risk (p = 0.830). Of the individual genes, none were associated with pancreatic cancer risk at a significance level of pVDR (rs2239186), LRP2 (rs4668123), CYP24A1 (rs2762932), GC (rs2282679), and CUBN (rs1810205) genes were the top SNPs associated with pancreatic cancer (p-values 0.008–0.037), but none were statistically significant after adjusting for multiple comparisons. Associations between these SNPs and pancreatic cancer were not modified by circulating concentrations of vitamin D. These findings do not support an association between vitamin D-related genes and pancreatic cancer risk. Future research should explore other pathways through which vitamin D status might be associated with pancreatic cancer risk.Keywords
This publication has 28 references indexed in Scilit:
- Plasma 25-Hydroxyvitamin D and Risk of Pancreatic CancerCancer Epidemiology, Biomarkers & Prevention, 2012
- Determinants of vitamin D status: focus on genetic variationsCurrent Opinion in Nephrology and Hypertension, 2011
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to KnowThe Journal of Clinical Endocrinology & Metabolism, 2011
- An Overview of Genetic Polymorphisms and Pancreatic Cancer Risk in Molecular Epidemiologic StudiesJournal of Epidemiology, 2011
- Common genetic determinants of vitamin D insufficiency: a genome-wide association studyThe Lancet, 2010
- Circulating 25-Hydroxyvitamin D and Risk of Pancreatic Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer CancersAmerican Journal of Epidemiology, 2010
- Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer CancersAmerican Journal of Epidemiology, 2010
- Genome-wide association study of circulating vitamin D levelsHuman Molecular Genetics, 2010
- Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studiesBritish Journal of Cancer, 2010
- A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33Nature Genetics, 2010